These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18695873)

  • 1. Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
    Yoshinaga K; Mimori K; Inoue H; Kamohara Y; Yamashita K; Tanaka F; Mori M
    Int J Oncol; 2008 Sep; 33(3):453-9. PubMed ID: 18695873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.
    Yoshinaga K; Yamashita K; Mimori K; Tanaka F; Inoue H; Mori M
    Ann Surg Oncol; 2008 Jan; 15(1):96-103. PubMed ID: 17909904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.
    Yoshinaga K; Inoue H; Utsunomiya T; Sonoda H; Masuda T; Mimori K; Tanaka Y; Mori M
    Clin Cancer Res; 2004 Sep; 10(17):5702-7. PubMed ID: 15355896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
    Xu H; Tanimoto A; Murata Y; Kimura S; Wang KY; Sasaguri Y
    Int J Oncol; 2003 Aug; 23(2):469-76. PubMed ID: 12851697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of the expression of activin A in esophageal carcinoma.
    Yoshinaga K; Mimori K; Yamashita K; Utsunomiya T; Inoue H; Mori M
    Int J Oncol; 2003 Jan; 22(1):75-80. PubMed ID: 12469187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
    Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
    Lynch CC; Crawford HC; Matrisian LM; McDonnell S
    Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
    Hou CH; Hsiao YC; Fong YC; Tang CH
    Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
    Yamashita K; Mori M; Shiraishi T; Shibuta K; Sugimachi K
    Clin Cancer Res; 2000 Mar; 6(3):1169-74. PubMed ID: 10741748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
    Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
    Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of activin E in glucose metabolism: transcriptional regulation of the inhibin/activin betaE subunit gene in the liver.
    Hashimoto O; Sekiyama K; Matsuo T; Hasegawa Y
    Life Sci; 2009 Sep; 85(13-14):534-40. PubMed ID: 19703474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells.
    Kaomongkolgit R; Cheepsunthorn P; Pavasant P; Sanchavanakit N
    Oral Oncol; 2008 Jun; 44(6):587-94. PubMed ID: 17936676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters.
    Izumiyama Y; Ohiro Y; Higashino F; Yoshida K; Taguchi K; Todo S; Kohgo T; Totsuka Y; Shindoh M
    Oncol Rep; 2005 Apr; 13(4):715-20. PubMed ID: 15756447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells.
    Marchenko ND; Marchenko GN; Weinreb RN; Lindsey JD; Kyshtoobayeva A; Crawford HC; Strongin AY
    Int J Biochem Cell Biol; 2004 May; 36(5):942-56. PubMed ID: 15006646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma.
    Zen K; Yasui K; Gen Y; Dohi O; Wakabayashi N; Mitsufuji S; Itoh Y; Zen Y; Nakanuma Y; Taniwaki M; Okanoue T; Yoshikawa T
    Oncogene; 2009 Aug; 28(32):2910-8. PubMed ID: 19503097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for AP-1 in matrix metalloproteinase production and invadopodia formation of v-Crk-transformed cells.
    Hasegawa H; Senga T; Ito S; Iwamoto T; Hamaguchi M
    Exp Cell Res; 2009 May; 315(8):1384-92. PubMed ID: 19268464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.